COVID-19 Impact on 3D Bioprinting Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on 3D Bioprinting Industry
1.7 COVID-19 Impact: 3D Bioprinting Market Trends
2 Global 3D Bioprinting Quarterly Market Size Analysis
2.1 3D Bioprinting Business Impact Assessment - COVID-19
2.1.1 Global 3D Bioprinting Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global 3D Bioprinting Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global 3D Bioprinting Quarterly Market Size, 2019 VS 2020
3.2 By Players, 3D Bioprinting Headquarters and Area Served
3.3 Date of Key Players Enter into 3D Bioprinting Market
3.4 Key Players 3D Bioprinting Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on 3D Bioprinting Segments, By Type
4.1 Introduction
1.4.1 Magnetic 3D Bioprinting
1.4.2 Laser-assisted Bioprinting
1.4.3 Inkjet 3D Bioprinting
1.4.4 Microextrusion 3D Bioprinting
4.2 By Type, Global 3D Bioprinting Market Size, 2019-2021
5 Impact of Covid-19 on 3D Bioprinting Segments, By Application
5.1 Overview
5.5.1 Clinical Applications
5.5.2 Research Applications
5.5.3 Drug and Medical Research
5.5.4 Regenerative Medicine
5.5.5 3D Cell Culture
5.2 By Application, Global 3D Bioprinting Market Size, 2019-2021
5.2.1 By Application, Global 3D Bioprinting Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Organovo Holdings Inc
7.1.1 Organovo Holdings Inc Business Overview
7.1.2 Organovo Holdings Inc 3D Bioprinting Quarterly Revenue, 2020
7.1.3 Organovo Holdings Inc 3D Bioprinting Product Introduction
7.1.4 Organovo Holdings Inc Response to COVID-19 and Related Developments
7.2 EnvisionTEC GmbH
7.2.1 EnvisionTEC GmbH Business Overview
7.2.2 EnvisionTEC GmbH 3D Bioprinting Quarterly Revenue, 2020
7.2.3 EnvisionTEC GmbH 3D Bioprinting Product Introduction
7.2.4 EnvisionTEC GmbH Response to COVID-19 and Related Developments
7.3 Nano3D Biosciences, Inc
7.3.1 Nano3D Biosciences, Inc Business Overview
7.3.2 Nano3D Biosciences, Inc 3D Bioprinting Quarterly Revenue, 2020
7.3.3 Nano3D Biosciences, Inc 3D Bioprinting Product Introduction
7.3.4 Nano3D Biosciences, Inc Response to COVID-19 and Related Developments
7.4 Cyfuse Biomedical K.K
7.4.1 Cyfuse Biomedical K.K Business Overview
7.4.2 Cyfuse Biomedical K.K 3D Bioprinting Quarterly Revenue, 2020
7.4.3 Cyfuse Biomedical K.K 3D Bioprinting Product Introduction
7.4.4 Cyfuse Biomedical K.K Response to COVID-19 and Related Developments
7.5 Advanced Solutions, Inc
7.5.1 Advanced Solutions, Inc Business Overview
7.5.2 Advanced Solutions, Inc 3D Bioprinting Quarterly Revenue, 2020
7.5.3 Advanced Solutions, Inc 3D Bioprinting Product Introduction
7.5.4 Advanced Solutions, Inc Response to COVID-19 and Related Developments
7.6 Aspect Biosystems Ltd
7.6.1 Aspect Biosystems Ltd Business Overview
7.6.2 Aspect Biosystems Ltd 3D Bioprinting Quarterly Revenue, 2020
7.6.3 Aspect Biosystems Ltd 3D Bioprinting Product Introduction
7.6.4 Aspect Biosystems Ltd Response to COVID-19 and Related Developments
7.7 3Dynamic Systems Ltd
7.7.1 3Dynamic Systems Ltd Business Overview
7.7.2 3Dynamic Systems Ltd 3D Bioprinting Quarterly Revenue, 2020
7.7.3 3Dynamic Systems Ltd 3D Bioprinting Product Introduction
7.7.4 3Dynamic Systems Ltd Response to COVID-19 and Related Developments
7.8 regenHU
7.8.1 regenHU Business Overview
7.8.2 regenHU 3D Bioprinting Quarterly Revenue, 2020
7.8.3 regenHU 3D Bioprinting Product Introduction
7.8.4 regenHU Response to COVID-19 and Related Developments
7.9 Cellink
7.9.1 Cellink Business Overview
7.9.2 Cellink 3D Bioprinting Quarterly Revenue, 2020
7.9.3 Cellink 3D Bioprinting Product Introduction
7.9.4 Cellink Response to COVID-19 and Related Developments
7.10 Regenovo Biotechnology Co., Ltd
7.10.1 Regenovo Biotechnology Co., Ltd Business Overview
7.10.2 Regenovo Biotechnology Co., Ltd 3D Bioprinting Quarterly Revenue, 2020
7.10.3 Regenovo Biotechnology Co., Ltd 3D Bioprinting Product Introduction
7.10.4 Regenovo Biotechnology Co., Ltd Response to COVID-19 and Related Developments
7.11 Poietis
7.11.1 Poietis Business Overview
7.11.2 Poietis 3D Bioprinting Quarterly Revenue, 2020
7.11.3 Poietis 3D Bioprinting Product Introduction
7.11.4 Poietis Response to COVID-19 and Related Developments
7.12 GeSiM
7.12.1 GeSiM Business Overview
7.12.2 GeSiM 3D Bioprinting Quarterly Revenue, 2020
7.12.3 GeSiM 3D Bioprinting Product Introduction
7.12.4 GeSiM Response to COVID-19 and Related Developments
7.13 Exone
7.13.1 Exone Business Overview
7.13.2 Exone 3D Bioprinting Quarterly Revenue, 2020
7.13.3 Exone 3D Bioprinting Product Introduction
7.13.4 Exone Response to COVID-19 and Related Developments
7.14 Stratasys
7.14.1 Stratasys Business Overview
7.14.2 Stratasys 3D Bioprinting Quarterly Revenue, 2020
7.14.3 Stratasys 3D Bioprinting Product Introduction
7.14.4 Stratasys Response to COVID-19 and Related Developments
7.15 Advanced BioMatrix
7.15.1 Advanced BioMatrix Business Overview
7.15.2 Advanced BioMatrix 3D Bioprinting Quarterly Revenue, 2020
7.15.3 Advanced BioMatrix 3D Bioprinting Product Introduction
7.15.4 Advanced BioMatrix Response to COVID-19 and Related Developments
7.16 Ricoh Company Ltd
7.16.1 Ricoh Company Ltd Business Overview
7.16.2 Ricoh Company Ltd 3D Bioprinting Quarterly Revenue, 2020
7.16.3 Ricoh Company Ltd 3D Bioprinting Product Introduction
7.16.4 Ricoh Company Ltd Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on 3D Bioprinting Assessment
Table 9. COVID-19 Impact: 3D Bioprinting Market Trends
Table 10. COVID-19 Impact Global 3D Bioprinting Market Size
Table 11. Global 3D Bioprinting Quarterly Market Size, 2020 (US$ Million)
Table 12. Global 3D Bioprinting Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global 3D Bioprinting Market Growth Drivers
Table 14. Global 3D Bioprinting Market Restraints
Table 15. Global 3D Bioprinting Market Opportunities
Table 16. Global 3D Bioprinting Market Challenges
Table 17. By Players, 3D Bioprinting Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, 3D Bioprinting Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key 3D Bioprinting Players Headquarters and Area Served
Table 20. Date of Key Players Enter into 3D Bioprinting Market
Table 21. Key Players 3D Bioprinting Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global 3D Bioprinting Market Size 2019-2021, (US$ Million)
Table 24. Global 3D Bioprinting Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global 3D Bioprinting Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa 3D Bioprinting Market Size, 2019-2021 (US$ Million)
Table 57. Organovo Holdings Inc Business Overview
Table 58. Organovo Holdings Inc 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Organovo Holdings Inc 3D Bioprinting Product
Table 60. Organovo Holdings Inc Response to COVID-19 and Related Developments
Table 61. EnvisionTEC GmbH Business Overview
Table 62. EnvisionTEC GmbH 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. EnvisionTEC GmbH 3D Bioprinting Product
Table 64. EnvisionTEC GmbH Response to COVID-19 and Related Developments
Table 65. Nano3D Biosciences, Inc Business Overview
Table 66. Nano3D Biosciences, Inc 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Nano3D Biosciences, Inc 3D Bioprinting Product
Table 68. Nano3D Biosciences, Inc Response to COVID-19 and Related Developments
Table 69. Cyfuse Biomedical K.K Business Overview
Table 70. Cyfuse Biomedical K.K 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Cyfuse Biomedical K.K 3D Bioprinting Product
Table 72. Cyfuse Biomedical K.K Response to COVID-19 and Related Developments
Table 73. Advanced Solutions, Inc Business Overview
Table 74. Advanced Solutions, Inc 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Advanced Solutions, Inc 3D Bioprinting Product
Table 76. Advanced Solutions, Inc Response to COVID-19 and Related Developments
Table 77. Aspect Biosystems Ltd Business Overview
Table 78. Aspect Biosystems Ltd 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Aspect Biosystems Ltd 3D Bioprinting Product
Table 80. Aspect Biosystems Ltd Response to COVID-19 and Related Developments
Table 81. 3Dynamic Systems Ltd Business Overview
Table 82. 3Dynamic Systems Ltd 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. 3Dynamic Systems Ltd 3D Bioprinting Product
Table 84. 3Dynamic Systems Ltd Response to COVID-19 and Related Developments
Table 85. regenHU Business Overview
Table 86. regenHU 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. regenHU 3D Bioprinting Product
Table 88. regenHU Response to COVID-19 and Related Developments
Table 89. Cellink Business Overview
Table 90. Cellink 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Cellink 3D Bioprinting Product
Table 92. Cellink Response to COVID-19 and Related Developments
Table 93. Regenovo Biotechnology Co., Ltd Business Overview
Table 94. Regenovo Biotechnology Co., Ltd 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Regenovo Biotechnology Co., Ltd 3D Bioprinting Product
Table 96. Regenovo Biotechnology Co., Ltd Response to COVID-19 and Related Developments
Table 97. Poietis Business Overview
Table 98. Poietis 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Poietis 3D Bioprinting Product
Table 100. Poietis Response to COVID-19 and Related Developments
Table 101. GeSiM Business Overview
Table 102. GeSiM 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. GeSiM 3D Bioprinting Product
Table 104. GeSiM Response to COVID-19 and Related Developments
Table 105. Exone Business Overview
Table 106. Exone 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Exone 3D Bioprinting Product
Table 108. Exone Response to COVID-19 and Related Developments
Table 109. Stratasys Business Overview
Table 110. Stratasys 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Stratasys 3D Bioprinting Product
Table 112. Stratasys Response to COVID-19 and Related Developments
Table 113. Advanced BioMatrix Business Overview
Table 114. Advanced BioMatrix 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Advanced BioMatrix 3D Bioprinting Product
Table 116. Advanced BioMatrix Response to COVID-19 and Related Developments
Table 117. Ricoh Company Ltd Business Overview
Table 118. Ricoh Company Ltd 3D Bioprinting Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Ricoh Company Ltd 3D Bioprinting Product
Table 120. Ricoh Company Ltd Response to COVID-19 and Related Developments
List of FiguresFigure 1. 3D Bioprinting Product Picture
Figure 2. 3D Bioprinting Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global 3D Bioprinting Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global 3D Bioprinting Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global 3D Bioprinting Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global 3D Bioprinting Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global 3D Bioprinting Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global 3D Bioprinting Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific 3D Bioprinting Market Size Market Share, 2019-2021